» Articles » PMID: 8505895

Monocrystalline Iron Oxide Nanocompounds (MION): Physicochemical Properties

Overview
Journal Magn Reson Med
Publisher Wiley
Specialty Radiology
Date 1993 May 1
PMID 8505895
Citations 124
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously described a novel monocrystalline iron oxide nanocompound (MION), a stable colloid that enables target specific MR imaging. In this study, the physicochemical properties of MION are reported using a variety of analytical techniques. High resolution electron microscopy indicates that a MION consists of hexagonal shaped electron-dense cores of 4.6 +/- 1.2 nm in diameter. This iron oxide core has an inverse spinel crystal structure which was confirmed by x-ray powder diffraction. Chemical analysis showed that each core has 25 +/- 6 dextran molecules (10 kD) attached, resulting in a unimodal hydrodynamic radius of 20 nm by laser light scattering. Because of the flexibility of the dextran layer, the radius is only 8 nm in nonaqueous reverse micelles. At room temperature, MION exhibit superparamagnetic behavior with an induced magnetization of 68 emu/g Fe at 1.5 T. Mössbauer studies show that the saturation internal magnetic field is 505 KOe, and blocking temperature is at 100 K. The R1 relaxivity of MION is 16.5 (mM.sec)-1 and the R2 relaxivity is 34.8 (mM.sec)-1 in aqueous solution at 37 degrees C and 0.47 T. In vitro phantom studies show that the detectability of MION in liver tissue is less than 50 nmol Fe/g tissue using gradient echo imaging techniques.

Citing Articles

Current developments and future perspectives of nanotechnology in orthopedic implants: an updated review.

Liang W, Zhou C, Bai J, Zhang H, Long H, Jiang B Front Bioeng Biotechnol. 2024; 12:1342340.

PMID: 38567086 PMC: 10986186. DOI: 10.3389/fbioe.2024.1342340.


Mapping cerebral perfusion in mice under various anesthesia levels using highly sensitive BOLD MRI with transient hypoxia.

Le T, Im G, Lee C, Choi S, Kim S Sci Adv. 2024; 10(9):eadm7605.

PMID: 38416820 PMC: 10901365. DOI: 10.1126/sciadv.adm7605.


Complement-dependent uptake of nanoparticles by blood phagocytes: brief overview and perspective.

Li Y, Moein Moghimi S, Simberg D Curr Opin Biotechnol. 2023; 85:103044.

PMID: 38091875 PMC: 11214757. DOI: 10.1016/j.copbio.2023.103044.


Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy.

Lorkowski M, Atukorale P, Ghaghada K, Karathanasis E Adv Healthc Mater. 2020; 10(5):e2001044.

PMID: 33225633 PMC: 7933107. DOI: 10.1002/adhm.202001044.


Applications of superparamagnetic iron oxide nanoparticles in drug and therapeutic delivery, and biotechnological advancements.

Suciu M, Ionescu C, Ciorita A, Tripon S, Nica D, Al-Salami H Beilstein J Nanotechnol. 2020; 11:1092-1109.

PMID: 32802712 PMC: 7404288. DOI: 10.3762/bjnano.11.94.